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Abstract: As a significant determinant of low back pain, intervertebral disc degeneration (IDD) has attracted more 
and more attention of both investigators and physicians. Disc herniation, termed as intervertebral disc displace-
ment, is amongst the most prevalent spinal diseases closely linked with IDD. Due to the same origins and similar 
pathophysiology, the ambiguity regarding the similarity and difference of IDD and intervertebral disc displacement 
thus remains. The aim of this study was to clarify the nomenclature of IDD and disc herniation in terms of molecular 
etiology, pathophysiology, nature history and clinical outcomes. Collectively, IDD is a type of multifaceted, progres-
sive spinal disease with or without clinical symptoms as back pain, characterized by extracellular matrix and the 
integrity of NP and AF lost, fissures formation. Disc herniation (termed as intervertebral disc displacement) is a type 
of spinal disease based on IDD or not, with local pain and/or sciatica due to mechanical compression and autoim-
mune cascades upon the corresponding nerve roots. Clarifying the nomenclature of intervertebral disc degenera-
tion and displacement has important implications both for investigators and for physicians.
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Introduction
Low back pain has an impact on 80% of the 
population with overwhelming health-care and 
socioeconomic burden globally [1]. There are 
numerous determinants of low back pain [2-4], 
the chief of which is intervertebral disc degen-
eration (IDD). During the past decade, studies 
addressing IDD intensified considerably in 
terms of both clinically and basically [5-7]. The 
basic studies of IDD can be divided into three 
major subsets, i.e, the etiology of IDD ranging 
from genetics [8, 9], microRNAs (miRNAs) [10-
13], molecular alterations to cellular function 
within the disc [14, 15], stem cell repair strate-
gies [16], artificial biomaterials mimic the natu-
ral hallmarks of the disc [17-20]. 
Despite more and more novel findings have 
been unraveled by the worldwide investigators, 
the nomenclature of IDD has not been well doc-
umented and clarified so far. On the other hand, 
disc herniation termed as intervertebral disc 
displacement, is amongst the most prevalent 
spinal diseases closely linked with IDD. Due to 
the same origins and similar pathophysiology, 
the ambiguity regarding the similarity and differ-
ence of IDD and intervertebral disc displace-
ment thus remains.
Normal intervertebral disc and immune privi-
lege 
The intervertebral disc plays important roles in 
the support, durability and flexibility of the spine 
by acting as mechanical stress absorber and 
transmitter on the basis of its unique structural 
feature. The disc is composed of 3 distinct but 
interlinked subparts: the outer layer as annulus 
fibrosus (AF), the central core as nucleus pulpo-
sus (NP) and the cartilage endplates connect-
ing the disc to the adjacent vertebral bodies. 
The structure of cells and tissues conforms to 
the requirements of their function. Within the 
harsh environment of the disc, there are large 
amounts of extracellular matrix but small 
amounts of highly specialized cells [21]. AF cells 
are elongated and polarized [22] in support of 
concentric lamellae consisting of both type-I 
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and type-II collagen; whereas NP cells in adults 
are small, rounded and chondrocyte-like in sup-
port of extracellular matrix rich in type-II colla-
gen and proteoglycans [23]. As localized within 
a nest under electron microscopy or capsule 
under light microscopy, both NP cells and AF 
cells are phagocytic in terms of autophagy and 
clearance of extracellular matrix and apoptotic 
cells [23-26]. 
Increasing evidence indicates that interverte-
bral disc belongs to immune privileged sites, 
owing to its avascular feature as well as molec-
ular basis, FasL expression of NP [27-32]. In 
parallel with the findings of local expression of 
FasL and Fas in human NP cells, we further 
demonstrate that FasL expression in NP cells 
contribute for the maintenance of the immune 
privilege of the disc by interacting with immuno-
cytes and vascular endothelial cells via both 
bound and soluble FasL-Fas machinery [33- 
35]. 
Intervertebral disc degeneration
With disc degeneration, the increasingly lost NP 
proteoglycans leads to reduced hydrodynamic 
transfer of axial stresses to the outer AF. 
Concurrently, the integrity of the AF is despoiled 
with radial fissures. The endplates undergo an 
ossification process and further reduce the 
nutritional supply to the disc. 
IDD is multifaceted, the etiology of which includ-
ing genetics [9], mechanical loading [14, 36, 
37], aberrant expression profiles of miRNAs 
[10, 13] and other molecules, such as CK8, 
link-N [15, 38]. Accumulating evidence based 
on the Twin Spine Study indicates that heredity 
plays a much bigger role than environmental 
factors [39]. It is noteworthy that small non-
coding RNAs, miRNAs, attract more and more 
attention in a variety of physiologic and patho-
logic processes. miRNAs are key post-transcrip-
tional regulators by interacting with 3’-UTRs of 
their repressed genes. We addressed the 
expression profiles of miRNAs in IDD and fur-
ther demonstrated that miR-155 promotes Fas-
mediated apoptosis in human IDD by targeting 
FADD and CASP3 [10]. Despite a few studies 
addressed several other miRNAs in IDD, includ-
ing miR-10b [13], the upstream regulation of 
miRNAs and their interaction with cytokines 
remain elusive.
As for the classification of IDD, there are clinical 
and histological schemes. Clinically, MRI is the 
current gold standard to assess the integrity of 
the disc. According to Pfirrmann and Boos [40], 
IDD can be classified as Grade I to V. As IDD 
progresses, the patients might complain low 
back pain rather than sciatica; whereas histo-
logical classification is proposed on the basis 
of degenerative hallmarks, such as cell clus-
ters, fissures extents and morphology of AF 
[41-43]. 
In 2012, IDD was introduced into the PubMed 
as a MeSH term with an OMIM code as 603932. 
However, the term has not been widely accept-
ed and used in the literature. A variety of other 
terms have been used, including IVDD, DDD 
(degenerative disc disease), LDD (lumbar disc 
degeneration), IVD degeneration etc. Unifying 
the term and nomenclature might be critical for 
global investigators and physicians.
The nomenclature of intervertebral disc de-
generation
Therefore, IDD is a type of multifaceted, pro-
gressive spinal disease with or without clinical 
symptoms as back pain, characterized by extra-
cellular matrix and the integrity of NP and AF 
lost, fissures formation. Moreover, IDD can 
exist in any part of the spine, including the cer-
vical and thoracic spine. The most frequent 
region with IDD is at C5/6 (men: 51.5%, women: 
46%), T6/7 (men: 32.4%, women: 37.7%), and 
L4/5 (men: 69.1%, women: 75.8%) [44]. 
As IDD develops, there are several types of out-
come. One is intervertebral disc displacement, 
or disc herniation with clinical symptoms as sci-
atica. The other might be the decreased disc 
height which eventually results in spontaneous 
fusion of the spinal level without clinical 
symptoms. 
The nomenclature of intervertebral disc dis-
placement
As a MeSH term, the intervertebral disc dis-
placement indicates the NP protrudes through 
the surrounding AF. Due to the anatomic hall-
marks of posterior longitudinal ligament [45] 
and the range of motion, disc herniation most 
frequently occurs in the lower lumbar region. 
Since the fissures in AF often develop in the 
posterolateral region [46], intervertebral disc 
displacement might protrude posterolaterally 
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to the adjacent nerve roots in the epidural 
region, resulting in sciatica. In addition to the 
compressive factors derived from the protru-
sion contributing to sciatica, the exposure of 
the immune-privileged NP triggers an autoim-
mune response involving macrophages, neu-
trophiles, T cells and B cells as well as proin-
flammatory cytokines, including interleukins 
and TNF-alpha [47-51]. Early clinical trials using 
TNF-alpha antagonists have been proven as a 
promising treatment option [52]. Patients with 
long term of herniation history might complain 
of numbness and motor weakness due to the 
immune cascades [53] in the region. 
It should be stressed that intervertebral disc 
displacement can derive not only from elder 
patients with considerably IDD, but also from 
adolescent patients with minimal IDD. The- 
refore, IDD and disc herniation are different but 
somewhat linked diseases. Patients with 
severe IDD complaining of low back pain usu-
ally undergo fusion from anterior approach; 
whereas patients with severe disc sequestra-
tion usually undergo posterior discectomy. The 
ambiguity regarding the nomenclature of these 
two disorders in the literature still remains. 
Future studies using disc specimens should 
clarify the disc derivation as IDD or interverte-
bral disc displacement to avoid conceptual con-
fusion and misleading. 
Summary
IDD is a type of multifaceted, progressive spi-
nal disease with or without clinical symptoms 
as back pain, characterized by extracellular 
matrix and the integrity of NP and AF lost, fis-
sures formation. Disc herniation (termed as 
intervertebral disc displacement) is a type of 
spinal disease based on IDD or not, with local 
pain and/or sciatica due to mechanical com-
pression and autoimmune cascades upon the 
corresponding nerve roots (Table 1). Clarifying 
the nomenclature of intervertebral disc degen-
eration and displacement has important impli-
cations both for investigators and for physi- 
cians. 
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